View in EDS

Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.

Saved in:
Bibliographic Details
Title: Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma.
Authors: Navone SE; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Marfia G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Health Sciences, Milan, Italy., Guarnaccia L; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Rizzaro M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy., Fiore G; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy., Campanella R; Andremacon Srl, Milan, Italy., Gaudino C; Azienda Ospedaliero Universitaria Policlinico Umberto I, Department of Neuroradiology, Rome, Italy., Santini D; Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Rome, Italy.; Azienda Ospedaliero Universitaria Policlinico Umberto I, Division of Oncology, Rome, Italy., Alotta GA; Andremacon Srl, Milan, Italy., Miozzo MR; University of Milan, Medical Genetics Unit, Department of Health Sciences, ASST Santi Paolo e Carlo, Milan, Italy., Barilla E; Andremacon Srl, Milan, Italy., Locatelli M; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Center for Aerospace Medicine and Advanced Therapies - CeMATA - Laboratory of Experimental Neurosurgery and Cell Therapy, Unit of Neurosurgery, Milan, Italy.; University of Milan, Department of Pathophysiology and Transplantation, Milan, Italy., Riboni L; Andremacon Srl, Milan, Italy. l.riboni@andremacon.com.
Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2025 Dec 26; Vol. 45 (1). Date of Electronic Publication: 2025 Dec 26.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1756-9966
DOI:10.1186/s13046-025-03620-3